<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJAnes</journal-id><journal-title-group><journal-title>Open Journal of Anesthesiology</journal-title></journal-title-group><issn pub-type="epub">2164-5531</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojanes.2015.53008</article-id><article-id pub-id-type="publisher-id">OJAnes-55005</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Evaluation of Pressure of Arterial Oxygen by Age in Supine Position during General Anesthesia
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>enichi</surname><given-names>Satoh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ayako</surname><given-names>Ohashi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Miho</surname><given-names>Kumagai</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Masahito</surname><given-names>Sato</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Akiyoshi</surname><given-names>Kuji</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shigeharu</surname><given-names>Joh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Division of Special Care Dentistry, Department of Developmental Oral Health Science, School of Dentistry, Iwate Medical University, Morioka, Japan</addr-line></aff><aff id="aff1"><addr-line>Division of Dental Anesthesiology, Department of Reconstructive Oral and Maxillofacial Surgery, School of Dentistry, Iwate Medical University, Morioka, Japan</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>satoken@iwate-med.ac.jp(ES)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>03</month><year>2015</year></pub-date><volume>05</volume><issue>03</issue><fpage>37</fpage><lpage>42</lpage><history><date date-type="received"><day>7</day>	<month>February</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>23</month>	<year>March</year>	</date><date date-type="accepted"><day>25</day>	<month>March</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: The concentration of supplemental O
  <sub>2</sub>
   should be measured during general anesthesia to determine whether patients’ pressure of arterial oxygen (PaO
  <sub>2</sub>
  ) is correct. Nevertheless, we do not know standard value of PaO
  <sub>2</sub>
   by age in supine position during general anesthesia. In this study, we evaluated the PaO
  <sub>2</sub>
   by age at 33% or 40% O
  <sub>2</sub>
   concentration. Materials and Methods: We retrospectively reviewed the anesthetic charts of 660 patients who were received general anesthesia from January 2001 to December 2013. Patients were divided into two groups by concentration of fraction of inspiratory oxygen: group at 33% or 40%. Second, patients aged 16 - 85 years were classified into 7 groups by age with each group covering one decade. Results: The PaO
  <sub>2</sub>
   was 185.1 &#177; 19.2 mmHg (33%) and 209.8 &#177; 19.8 mmHg (40%) at age 16 - 25 years, 178.7 &#177; 23.6 mmHg (33%) and 202.7 &#177; 26.0 mmHg (40%) at age 26 - 35 years, 165.8 &#177; 30.6 mmHg (33%) and 188.9 &#177; 22.2 (40%) mmHg at age 36 - 45 years, 154.1 &#177; 22.8 mmHg (33%) and 181.8 &#177; 19.2 (40%) mmHg at age 46 - 55 years, 153.7 &#177; 21.7 mmHg (33%) and 177.5 &#177; 18.1 mmHg (40%) at age 56 - 65 years, 152.2 &#177; 24.5 mmHg and 171.0 &#177; 22.1 mmHg at age 66 - 75 years, and 154.6 &#177; 24.3 mmHg and 174.1 &#177; 20.2 mmHg at age 76 - 85 years. Conclusion:
   
  The PaO
  <sub>2</sub>
   tended to decrease with age at both 33% and 40% O
  <sub>2</sub>
   concentration.
 
</p></abstract><kwd-group><kwd>Pressure of Arterial Oxygen</kwd><kwd> Supine Position</kwd><kwd> Age</kwd><kwd> General Anesthesia</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>In patients in the supine position, general anesthesia induces atelectasis formation, a reduction in lung volume, and respiratory mechanical impairment that may be associated with gas exchange abnormalities [<xref ref-type="bibr" rid="scirp.55005-ref1">1</xref>] . An increase in the intra-abdominal pressure and consequent cephalad displacement of the diaphragm caused by the anesthetic procedure account for the occurrence of atelectasis in the most dependent lung regions and are associated with oxygenation impairment after anesthetic induction [<xref ref-type="bibr" rid="scirp.55005-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.55005-ref3">3</xref>] . Anesthesia may thus produce more adverse effects on respiratory function in patients in supine position.</p><p>The concentration of supplemental O<sub>2</sub> should be measured during general anesthesia to determine whether patients’ pressure of arterial oxygen (PaO<sub>2</sub>) is correct. However, the standard PaO<sub>2</sub> value undergoing oral and maxillofacial surgery in the supine position during general anesthesia is unknown.</p><p>In this study, the PaO<sub>2</sub> was evaluated with respect to F<sub>I</sub>O<sub>2</sub> and age in patients undergoing oral and maxillofacial surgery during general anesthesia. Because there have been very few previous reports evaluating PaO<sub>2</sub> with respect to F<sub>I</sub>O<sub>2</sub> and age in this clinical situation, we do not know the standard value of PaO<sub>2</sub> in this patient population. Therefore, this study was designed to obtain the standard value of PaO<sub>2</sub> according to F<sub>I</sub>O<sub>2</sub> and age in patients in supine position during general anesthesia.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>This retrospective study was approved by the Committee on Clinical Investigation for human research at Iwate Medical University.</p><p>We evaluated 660 patients aged ≥ 16 years who underwent general anesthesia in the supine position between January 2001 and December 2013. The anesthetic charts of these 660 patients, all classified as American Society of Anesthesiologists physical status I or II (with the exception of patients with conditions such as asthma, respiratory disease, obesity [body mass index of ≥25 kg/m<sup>2</sup>], and smoking), were retrospectively reviewed to investigate age, height, weight, % forced vital capacity (%FVC), % forced expiratory volume in 1 second (FEV<sub>1.0</sub>%), and PaO<sub>2</sub>. First, patients were divided into two groups by concentration of fraction of inspiratory oxygen (F<sub>I</sub>O<sub>2</sub>): group at 33% F<sub>I</sub>O<sub>2</sub> and group at 40% F<sub>I</sub>O<sub>2</sub>. Second, patients aged 16 - 85 years were classified into 7 groups by age with each group covering one decade: in group at 33% F<sub>I</sub>O<sub>2, </sub>group A (aged 16 - 25 years), group B (26 - 35 years), group C (36 - 45 years), group D (46 - 55 years), group E (56 - 65 years), group F (66 - 75 years), and group G (76 - 85 years), in group at 40% F<sub>I</sub>O<sub>2</sub>, group H (aged 16 - 25 years), group I (26 - 35 years), group J (36 - 45 years), group K (46 - 55 years), group L (56 - 65 years), group M (66 - 75 years), and group N (76 - 85 years).</p><p>Anesthesia was induced with intravenous (IV) propofol (1 - 2 mg/kg of ideal body weight) or thiopental sodium (3 - 5 mg/kg of ideal body weight). Muscle relaxation was provided with vecuronium bromide (0.1 mg/kg of ideal body weight) or rocuronium bromide (0.8 mg/kg of ideal body weight). After tracheal intubation, anesthesia was maintained in almost all patients with sevoflurane (1% - 2%) and nitrous oxide gas if necessary, and patients were mechanically ventilated. We usually used RAE cuffed tracheal tubes (Cuffed Murphy Eye<sup>&#174;</sup>; Covidien, Mallinckrodt, Ireland) for oral and Parker Flex-Tip<sup>&#174;</sup> PFHV tubes (Parker Medical, Highlands Ranch) for nasal intubation. The ventilatory settings were as follows: tidal volume, 8 - 10 ml/kg of ideal body weight; respiratory rate, 10 - 12 breaths/minute; peak airway pressure, below 20 cm H<sub>2</sub>O; PEEP, 0 cm H<sub>2</sub>O; and inspiratory oxygen concentration, 33% or 40%. After 30 to 60 minutes of stabilization following the start of the operation, a blood sample was drawn from the radial artery or the dorsalis pedis artery and analyzed for blood gases.</p><p>Values are presented as mean &#177; standard deviation. Statistical analysis was performed using SPSS, version 11.0 (SPSS, Inc., Chicago, IL, USA). Statistical analysis employed one-way analysis of variance followed by multiple-comparison testing using the Scheffe test for comparisons among groups. The relationship between PaO<sub>2</sub> and age was investigated by Pearson’s correlation coefficient test. Correlation coefficients were obtained using simple regression analysis (Excel software, 2003; Microsoft, Redmond, WA, USA). Differences were considered statistically significant at a P value of &lt; 0.05.</p></sec><sec id="s3"><title>3. Results</title><p>Patients’ characteristics and laboratory data are presented in <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>Regarding groups A - G there were significant differences in age (among all seven groups), height (group G compared with groups A, B, C, D and E; group F compared with groups A, B and C; group E compared with</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Patient profiles and laboratory data by age. Comparison among groups according to patient age (from 16 to 85 years in one decade increments) at 33% of O<sub>2</sub> concentration</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Group</th><th align="center" valign="middle" >A (16 - 25 years)</th><th align="center" valign="middle"  colspan="2"  >B (26 - 35 years)</th><th align="center" valign="middle"  colspan="2"  >C (36 - 45 years)</th><th align="center" valign="middle" >D (46 - 55 years)</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >105</td><td align="center" valign="middle"  colspan="2"  >58</td><td align="center" valign="middle"  colspan="2"  >49</td><td align="center" valign="middle" >47</td></tr><tr><td align="center" valign="middle" >Age (yrs)</td><td align="center" valign="middle" >20.6 &#177; 2.8</td><td align="center" valign="middle"  colspan="2"  >29.5 &#177; 2.9<sup>*</sup></td><td align="center" valign="middle"  colspan="2"  >41.0 &#177; 2.6<sup>*</sup><sup>,</sup><sup>#</sup></td><td align="center" valign="middle" >51.7 &#177; 2.7<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;</sup></td></tr><tr><td align="center" valign="middle" >Height (cm)</td><td align="center" valign="middle" >166.0 &#177; 8.7</td><td align="center" valign="middle"  colspan="2"  >167.3 &#177; 8.0</td><td align="center" valign="middle"  colspan="2"  >165.1 &#177; 7.8</td><td align="center" valign="middle" >160.9 &#177; 8.9<sup>#</sup></td></tr><tr><td align="center" valign="middle" >Weight (kg)</td><td align="center" valign="middle" >57.7 &#177; 9.5</td><td align="center" valign="middle"  colspan="2"  >59.4 &#177; 9.9</td><td align="center" valign="middle"  colspan="2"  >60.5 &#177; 10.1</td><td align="center" valign="middle" >58.6 &#177; 10.4</td></tr><tr><td align="center" valign="middle" >%FVC (%)</td><td align="center" valign="middle" >105.8 &#177; 16.8</td><td align="center" valign="middle"  colspan="2"  >114.3 &#177; 14.6</td><td align="center" valign="middle"  colspan="2"  >110.5 &#177; 19.0</td><td align="center" valign="middle" >109.3 &#177; 14.9</td></tr><tr><td align="center" valign="middle" >FEV<sub>1.0</sub>% (%)</td><td align="center" valign="middle" >90.6 &#177; 10.1</td><td align="center" valign="middle"  colspan="2"  >85.6 &#177; 6.1</td><td align="center" valign="middle"  colspan="2"  >83.1 &#177; 5.8<sup>*</sup></td><td align="center" valign="middle" >81.0 &#177; 6.4<sup>*</sup><sup>,</sup><sup>#</sup></td></tr><tr><td align="center" valign="middle" >PaO<sub>2</sub> (mmHg)</td><td align="center" valign="middle" >185.1 &#177; 19.2</td><td align="center" valign="middle"  colspan="2"  >178.7 &#177; 23.6</td><td align="center" valign="middle"  colspan="2"  >165.8 &#177; 30.6<sup>*</sup></td><td align="center" valign="middle" >154.1 &#177; 22.8<sup>*</sup><sup>,</sup><sup>#</sup></td></tr><tr><td align="center" valign="middle" >Group</td><td align="center" valign="middle"  colspan="2"  >E (56 - 65 years)</td><td align="center" valign="middle"  colspan="2"  >F (66 - 75 years)</td><td align="center" valign="middle"  colspan="2"  >G (76 - 85 years)</td></tr><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle"  colspan="2"  >45</td><td align="center" valign="middle"  colspan="2"  >67</td><td align="center" valign="middle"  colspan="2"  >46</td></tr><tr><td align="center" valign="middle" >Age (yrs)</td><td align="center" valign="middle"  colspan="2"  >60.5 &#177; 2.4<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;,†</sup></td><td align="center" valign="middle"  colspan="2"  >69.0 &#177; 3.1<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;,†,‡</sup></td><td align="center" valign="middle"  colspan="2"  >78.2 &#177; 2.7<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;,†,‡,</sup><sup>⁑</sup></td></tr><tr><td align="center" valign="middle" >Height (cm)</td><td align="center" valign="middle"  colspan="2"  >159.6 &#177; 7.7<sup>#</sup><sup>,&#167;</sup></td><td align="center" valign="middle"  colspan="2"  >157.5 &#177; 9.0<sup>*</sup><sup>,</sup><sup>＃</sup><sup>,&#167;</sup></td><td align="center" valign="middle"  colspan="2"  >162.6 &#177; 8.2<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;,†,‡</sup></td></tr><tr><td align="center" valign="middle" >Weight (kg)</td><td align="center" valign="middle"  colspan="2"  >54.8 &#177; 7.6</td><td align="center" valign="middle"  colspan="2"  >54.7 &#177; 7.9</td><td align="center" valign="middle"  colspan="2"  >48.5 &#177; 9.4<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;</sup></td></tr><tr><td align="center" valign="middle" >%FVC (%)</td><td align="center" valign="middle"  colspan="2"  >113.1 &#177; 15.5</td><td align="center" valign="middle"  colspan="2"  >111.0 &#177; 17.1</td><td align="center" valign="middle"  colspan="2"  >98.4 &#177; 20.2<sup>#</sup><sup>,‡,</sup><sup>⁑</sup></td></tr><tr><td align="center" valign="middle" >FEV<sub>1.0</sub>% (%)</td><td align="center" valign="middle"  colspan="2"  >80.1 &#177; 6.0<sup>*</sup><sup>,</sup><sup>#</sup></td><td align="center" valign="middle"  colspan="2"  >78.4 &#177; 4.3<sup>*</sup><sup>,</sup><sup>#</sup></td><td align="center" valign="middle"  colspan="2"  >77.9 &#177; 6.0<sup>*</sup><sup>,</sup><sup>#</sup></td></tr><tr><td align="center" valign="middle" >PaO<sub>2</sub> (mmHg)</td><td align="center" valign="middle"  colspan="2"  >153.7 &#177; 21.7<sup>*</sup><sup>,</sup><sup>#</sup></td><td align="center" valign="middle"  colspan="2"  >152.2 &#177; 24.5<sup>*</sup><sup>,</sup><sup>#</sup></td><td align="center" valign="middle"  colspan="2"  >154.6 &#177; 24.3<sup>*</sup><sup>,</sup><sup>#</sup></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p><sup>*</sup>p &lt; 0.05 vs group A, <sup>#</sup>p &lt; 0.05 vs group B, <sup>&#167;</sup>p &lt; 0.05 vs group C; <sup>†</sup>p &lt; 0.05 vs group D, <sup>‡</sup>p&lt;0.05 vs group E, <sup>⁑</sup>p &lt; 0.05 vs group F.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Patient profiles and laboratory data by age. Comparison among groups according to patient age (from 16 to 85 years in one decade increments) at 40% of O<sub>2 </sub>concentration</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Group</th><th align="center" valign="middle" >H (16 - 25 years)</th><th align="center" valign="middle"  colspan="2"  >I (26 - 35 years)</th><th align="center" valign="middle"  colspan="2"  >J (36 - 45 years)</th><th align="center" valign="middle" >K (46 - 55 years)</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >41</td><td align="center" valign="middle"  colspan="2"  >33</td><td align="center" valign="middle"  colspan="2"  >36</td><td align="center" valign="middle" >33</td></tr><tr><td align="center" valign="middle" >Age (yrs)</td><td align="center" valign="middle" >19.7 &#177; 3.0</td><td align="center" valign="middle"  colspan="2"  >30.3 &#177; 2.8<sup>*</sup></td><td align="center" valign="middle"  colspan="2"  >40.7 &#177; 2.9<sup>*</sup><sup>,</sup><sup>#</sup></td><td align="center" valign="middle" >50.7 &#177; 2.8<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;</sup></td></tr><tr><td align="center" valign="middle" >Height (cm)</td><td align="center" valign="middle" >165.1 &#177; 9.7</td><td align="center" valign="middle"  colspan="2"  >164.3 &#177; 9.4</td><td align="center" valign="middle"  colspan="2"  >165.0 &#177; 8.9</td><td align="center" valign="middle" >162.8 &#177; 8.7</td></tr><tr><td align="center" valign="middle" >Weight (kg)</td><td align="center" valign="middle" >59.4 &#177; 10.5</td><td align="center" valign="middle"  colspan="2"  >57.1 &#177; 9.4</td><td align="center" valign="middle"  colspan="2"  >60.8 &#177; 11.3</td><td align="center" valign="middle" >58.3 &#177; 7.2</td></tr><tr><td align="center" valign="middle" >%FVC (%)</td><td align="center" valign="middle" >107.3 &#177; 14.1</td><td align="center" valign="middle"  colspan="2"  >114.7 &#177; 16.4</td><td align="center" valign="middle"  colspan="2"  >114.0 &#177; 17.1</td><td align="center" valign="middle" >120.6 &#177; 11.2<sup>*</sup></td></tr><tr><td align="center" valign="middle" >FEV<sub>1.0</sub>% (%)</td><td align="center" valign="middle" >90.3 &#177; 10.7</td><td align="center" valign="middle"  colspan="2"  >87.5 &#177; 5.4</td><td align="center" valign="middle"  colspan="2"  >83.9 &#177; 6.4</td><td align="center" valign="middle" >81.5 &#177; 4.1<sup>*</sup></td></tr><tr><td align="center" valign="middle" >PaO<sub>2</sub> (mmHg)</td><td align="center" valign="middle" >209.8 &#177; 19.8</td><td align="center" valign="middle"  colspan="2"  >202.7 &#177; 26.0</td><td align="center" valign="middle"  colspan="2"  >188.9 &#177; 22.2<sup>*</sup></td><td align="center" valign="middle" >181.8 &#177; 19.2<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Group</td><td align="center" valign="middle"  colspan="2"  >L (56 - 65 years)</td><td align="center" valign="middle"  colspan="2"  >M (66 - 75 years)</td><td align="center" valign="middle"  colspan="2"  >N (76 - 85 years)</td></tr><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle"  colspan="2"  >32</td><td align="center" valign="middle"  colspan="2"  >38</td><td align="center" valign="middle"  colspan="2"  >30</td></tr><tr><td align="center" valign="middle" >Age (yrs)</td><td align="center" valign="middle"  colspan="2"  >61.4 &#177; 2.4<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;,†</sup></td><td align="center" valign="middle"  colspan="2"  >70.1 &#177; 3.0<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;,†,‡</sup></td><td align="center" valign="middle"  colspan="2"  >79.9 &#177; 3.2<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;,†,‡,</sup><sup>⁑</sup></td></tr><tr><td align="center" valign="middle" >Height (cm)</td><td align="center" valign="middle"  colspan="2"  >158.0 &#177; 7.6</td><td align="center" valign="middle"  colspan="2"  >155.5 &#177; 8.9<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;</sup></td><td align="center" valign="middle"  colspan="2"  >152.0 &#177; 8.0<sup>*</sup><sup>,</sup><sup>#</sup><sup>,&#167;,†,</sup><sup> ‡</sup></td></tr><tr><td align="center" valign="middle" >Weight (kg)</td><td align="center" valign="middle"  colspan="2"  >55.3 &#177; 9.1</td><td align="center" valign="middle"  colspan="2"  >52.5 &#177; 10.0</td><td align="center" valign="middle"  colspan="2"  >49.3 &#177; 6.8<sup>*</sup><sup>,</sup><sup>&#167;</sup></td></tr><tr><td align="center" valign="middle" >%FVC (%)</td><td align="center" valign="middle"  colspan="2"  >118.4 &#177; 15.0<sup>*</sup></td><td align="center" valign="middle"  colspan="2"  >111.4 &#177; 16.7</td><td align="center" valign="middle"  colspan="2"  >106.7 &#177; 20.6<sup>*</sup><sup>,†,‡</sup></td></tr><tr><td align="center" valign="middle" >FEV<sub>1.0</sub>% (%)</td><td align="center" valign="middle"  colspan="2"  >80.2 &#177; 2.9<sup>*</sup><sup>,</sup><sup>#</sup></td><td align="center" valign="middle"  colspan="2"  >79.2 &#177; 5.2<sup>*</sup><sup>,</sup><sup>#</sup></td><td align="center" valign="middle"  colspan="2"  >82.0 &#177; 14.8</td></tr><tr><td align="center" valign="middle" >PaO<sub>2</sub> (mmHg)</td><td align="center" valign="middle"  colspan="2"  >177.5 &#177; 18.1<sup>*</sup></td><td align="center" valign="middle"  colspan="2"  >171.0 &#177; 22.1<sup>*</sup><sup>,</sup><sup>#</sup></td><td align="center" valign="middle"  colspan="2"  >174.1 &#177; 20.2<sup>*</sup><sup>,</sup><sup>#</sup></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p><sup>*</sup>p &lt; 0.05 vs group H, <sup>#</sup>p &lt; 0.05 vs group I, <sup>&#167;</sup>p &lt; 0.05 vs group J; <sup>†</sup>p &lt; 0.05 vs group K, <sup>‡</sup>p &lt; 0.05 vs group L, <sup>⁑</sup>p &lt; 0.05 vs group M.</p><p>groups A and C; and group D compared with group B), weight (group G compared with groups A, B and C), %FVC (group G compared with groups A, E and F), FEV<sub>1.0</sub>% (groups D, E, F, G compared with groups A and B and group C compared with group A), and PaO<sub>2</sub> (groups D, E, F, G compared with groups A and B and group C compared with group A). The PaO<sub>2</sub> was 185.1 &#177; 19.2 mmHg at age 16 - 25 years, 178.7 &#177; 23.6 mmHg at age 26 - 35 years, 165.8 &#177; 30.6 mmHg at age 36 - 45 years, 154.1 &#177; 22.8 mmHg at age 46-55 years, 153.7 &#177; 21.7 mmHg at age 56 - 65 years, 152.2 &#177; 24.5 mmHg at age 66 - 75 years, and 154.6 &#177; 24.3 mmHg at age 76 - 85 years (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Regarding groups H-N there were significant differences in age (among all seven groups), height (group N compared with groups H, I, J, K and L; and group M compared with groups H, I and J), weight (group N compared with groups A, B and C), %FVC (group N compared with group K and L, and groups K and L compared with group A), FEV<sub>1.0</sub>% (groups L and M compared with groups H and I and group K compared with group H), and PaO<sub>2</sub> (groups M and N compared with groups A and B and groups J, K, L compared with group H). The PaO<sub>2</sub> was 209.8 &#177; 19.8 mmHg at age 16 - 25 years, 202.7 &#177; 26.0 mmHg at age 26 - 35 years, 188.9 &#177; 22.2 mmHg at age 36 - 45 years, 181.8 &#177; 19.2 mmHg at age 46 - 55 years, 177.5 &#177; 18.1 mmHg at age 56 - 65 years, 171.0 &#177; 22.1 mmHg at age 66 - 75 years, and 174.1 &#177; 20.2 mmHg at age 76 - 85 years (<xref ref-type="table" rid="table2">Table 2</xref>). There was also a negative correlation between PaO<sub>2</sub> and age (r = 0.500, slop = −0.6288, P &lt; 0.05 and R<sup>2</sup> = 0.2505) in group at 33% F<sub>I</sub>O<sub>2</sub>, and there was a negative correlation between the two (r = 0.424, slop = −0.6024, P &lt; 0.05 and R<sup>2</sup> = 0.18) in group at 40% F<sub>I</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>There is also a negative correlation between PaO<sub>2</sub> and age (r = 0.500, slop = −0.6288, P &lt; 0.05 and R<sup>2</sup> = 0.2505) in group at 33% F<sub>I</sub>O<sub>2</sub>, and a negative correlation between the two (r = 0.424, slop = −0.6024, P &lt; 0.05 and R<sup>2</sup> = 0.18) in group at 40% F<sub>I</sub>O<sub>2</sub>.</p></sec><sec id="s4"><title>4. Discussion</title><p>In the present study, we found out two important issues. The value of PaO<sub>2</sub> according to F<sub>I</sub>O<sub>2</sub> at 33% or 40% inhalation is obtained in supine position during general anesthesia. The PaO<sub>2</sub> tends to decrease with increasing age for patients anesthetized in the supine position.</p><p>First, the value of PaO<sub>2</sub> according to F<sub>I</sub>O<sub>2</sub> at 33% or 40% inhalation was obtained in supine position during general anesthesia. In this study, when the value of PaO<sub>2</sub> is compared with group at 33% and group at 40% O<sub>2</sub> concentration, it is suggested that the value of PaO<sub>2</sub> in all age at 33% O<sub>2</sub> concentration plus almost 20 mmHg is the value of PaO<sub>2</sub> at 40% O<sub>2</sub> in all age. Generally, the ideal standard value of PaO<sub>2</sub> at 33% O<sub>2</sub> concentration is almost 185 mmHg at 40% concentration is almost 230 mmHg. In this study the value of PaO<sub>2</sub> was almost same value as or lower than the ideal standard value but was thought to be within the clinically acceptable range in all groups. And in group at 33% O<sub>2</sub> concentration, the value of PaO<sub>2</sub> decreases by almost 10 mmHg with age from 16 - 25 years to 46 - 65 years and that of group at age 46 - 55 years, group at age 56 - 65 years, group at age 66 - 75 years and group at age 76 - 85 years are almost same value. In both group at 33% and group at 40% O<sub>2</sub> concentration, the value of PaO<sub>2</sub> in group 66 - 75 years is lowest among seven groups. Nevertheless, we do not have</p><fig-group id="fig1"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Relationship between pressure of arterial oxygen and age. (a) Fraction of inspiratory oxygen at 33% inhalation; (b) Fraction of inspiratory oxygen at 40% inhalation.</title></caption><fig id ="fig1_1"><label> (b)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1920334x6.png"/></fig></fig-group><p>enough data to judge why the value of PaO<sub>2</sub> in group 66-75 years is lowest. Become aware of the value of PaO<sub>2</sub> by age also suggests that we could know whether patients’ PaO<sub>2</sub> is low or not and determine the concentration of supplemental O<sub>2</sub>. In addition, general anesthesia is more safely performed.</p><p>Second, the PaO<sub>2</sub> tends to decrease with increasing age for patients anesthetized in the supine position. There was also a negative correlation between PaO<sub>2</sub> and age in group at 33% and 40% F<sub>I</sub>O<sub>2</sub>. Pulmonary gas exchange is impaired during general anesthesia [<xref ref-type="bibr" rid="scirp.55005-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.55005-ref5">5</xref>] . It is also generally held that the gas exchange impairment in anaesthetized subjects increases with age [<xref ref-type="bibr" rid="scirp.55005-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.55005-ref6">6</xref>] .<sup> </sup>During inhalation anesthesia with mechanical ventilation, atelectasis and shunt developed, however, atelectasis and shunt did not increase significantly with age, shunt influenced PaO<sub>2</sub> most, low ventilation/perfusion ratios being a secondary factor which, was increasingly important with increasing age, thus explaining the well-known age-dependent deterioration of arterial oxygenation during anesthesia [<xref ref-type="bibr" rid="scirp.55005-ref5">5</xref>] . And the major cause of impaired oxygenation of the blood was shunt, an effect of prompt atelectasis formation in dependent lung regions and was ventilation/perfusion (V/Q) mismatch, and the magnitude of shunt and size of atelectasis were independent of the age of the patient, whereas V/Q mismatch increased with age, explaining the age dependent impairment of oxygenation [<xref ref-type="bibr" rid="scirp.55005-ref7">7</xref>] . Negative correlations were found between PaO<sub>2</sub> and age in both group at 33% F<sub>I</sub>O<sub>2</sub> (r = 0.500, P &lt; 0.05) and group at 40% F<sub>I</sub>O<sub>2 </sub>(r = 0.424, P &lt; 0.05). The regression lines using PaO<sub>2 </sub>as outcome variable (y) and age as predictor variable (x) were y = −0.6288x + 195.79 (group at 33% F<sub>I</sub>O<sub>2</sub>) and y = −0.6024x + 218.46 (group at 33% F<sub>I</sub>O<sub>2</sub>). We believe that these data can help to predict the outcome of the PaO<sub>2</sub> value by age in the supine position during general anesthesia.</p></sec><sec id="s5"><title>5. Conclusion</title><p>The standard value of PaO<sub>2</sub> according to F<sub>I</sub>O<sub>2</sub> at 33% or 40% inhalation was obtained and the PaO<sub>2</sub> tended to decrease with age in supine position during general anesthesia. Become aware of the value of PaO<sub>2</sub> by age at 33% or 40% O<sub>2</sub> concentration and also suggests that we could know whether patients’ PaO<sub>2</sub> is low or not and determine the concentration of supplemental O<sub>2</sub>. In addition, general anesthesia is more safely performed.</p></sec><sec id="s6"><title>Conflict of Interests</title><p>The authors declare that they received no financial support and have no conflict of interests.</p></sec><sec id="s7"><title>Abbreviations</title><p>PaO<sub>2</sub>: Pressure of arterial oxygen <sub></sub></p><p>F<sub>I</sub>O<sub>2</sub>: Fraction of inspiratory oxygen</p><p>%FVC: % forced vital capacity</p><p>FEV<sub>1.0</sub>%: % forced expiratory volume in 1 second</p></sec><sec id="s8"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.55005-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Mohamed Hoesein, F.A., Zanen, P. and Lammers, J.W. (2011) Lower Limit of Normal or FEV1/FVC &lt; 0.70 in Diagnosing COPD: An Evidence-Based Review. Respiratory Medicine, 105, 907-915. http://dx.doi.org/10.1016/j.rmed.2011.01.008</mixed-citation></ref><ref id="scirp.55005-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Milledge, J. and Nunn, J.F. (1975) Criteria of Fitness for Anaesthesia in Patients with Chronic Obstructive Lung Disease. British Medical Journal, 3, 670-673. http://dx.doi.org/10.1136/bmj.3.5985.670</mixed-citation></ref><ref id="scirp.55005-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Swanney, M.P., Ruppel, G., Enright, P.L., Pederson, O.F., Crapo, R.O., Miller, M.R., Jensen, R.L., Falaschetti, E., Schouten, J.P., Hankinson, J.L., Stocks, J. and Quanje, P.H. (2008) Using the Lower Limit of Normal for the FEV1/ FVC Ratio Reduces the Misclassification of Airway Obstruction. Thorax, 63, 1046-1051. http://dx.doi.org/10.1136/thx.2008.098483</mixed-citation></ref><ref id="scirp.55005-ref4"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hedenstierna</surname><given-names> G. </given-names></name>,<etal>et al</etal>. (<year>1994</year>)<article-title>Atelectasis Formation and Gas Exchange Impairment during Anaesthesia</article-title><source> Monaldi Archives for Chest Disease</source><volume> 49</volume>,<fpage> 315</fpage>-<lpage>322</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.55005-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Brismar, B., Hedenstrierna, G., Lundquist, H., Strandberg, A., Svensson, L. and Tokics, L. (1985) Pulmonary Densities during Anesthesia with Muscular Relaxation—A Proposal of Atelectasis. Anesthesiology, 65, 422-428. http://dx.doi.org/10.1097/00000542-198504000-00009</mixed-citation></ref><ref id="scirp.55005-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Gunnarsson, L., Tokics, L., Gustavsson, H. and Hedenstierna, G. (1991) Influence of Age on Atelectasia Formation and Gas Exchange Impairment during General Anaesthesia. British Journal of Anaesthesia, 66, 423-432. http://dx.doi.org/10.1093/bja/66.4.423</mixed-citation></ref><ref id="scirp.55005-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Stanojevic, S., Wade, A. and Stocks, J. (2010) Reference Values for Lung Function: Past, Present and Future. European Respiratory Journal, 36, 12-19. http://dx.doi.org/10.1183/09031936.00143209</mixed-citation></ref></ref-list></back></article>